back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-08 10:02 Tx date 2024-02-05 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+55,000 vol |
134,999 | |
| Filed 2023-08-18 09:41 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Holder: Fletcher Payne 2019 Trust (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-9,334 vol |
666 | |
| Filed 2023-08-18 09:39 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,120,001 vol |
79,999 | |
| Filed 2023-08-18 09:38 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-93,334 vol |
6,666 | |
| Filed 2023-01-24 15:44 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+100,000 vol |
100,000 | |
| Filed 2023-01-24 15:43 Tx date 2022-06-27 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-24 15:43 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-100,000 vol |
0 | |
| Filed 2023-01-24 15:42 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
100,000 | |
| Filed 2023-01-24 15:42 Tx date 2022-06-27 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-24 15:42 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
1,200,000 | |
| Filed 2022-09-22 10:01 Tx date 2022-09-19 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Holder: Fletcher Payne 2019 Trust (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,775
+10,000 vol $0.68 each |
10,000 |